Gene/Protein
Disease
Symptom
Drug
Enzyme
Compound
Pivot Concepts:
Gene/Protein
Disease
Symptom
Drug
Enzyme
Compound
Target Concepts:
Gene/Protein
Disease
Symptom
Drug
Enzyme
Compound
Query: EC:3.4.25.1 (
proteasome
)
28,817
document(s) hit in 31,850,051 MEDLINE articles (0.00 seconds)
The generation of peptides presented by MHC class I molecules requires the proteolytic activity of the
proteasome
and/or other peptidases. The processing of a short vaccinia virus-encoded antigen can take place by a
proteasome
-independent pathway involving initiator
caspase-5
and -10, which generate antigenic peptides recognized by CD8(+) T lymphocytes. In the present study, comparing single versus double enzyme digestions by mass spectrometry analysis, both qualitative and quantitative differences in the products obtained were identified. These in vitro data suggest that each enzyme can use the degradation products of the other as substrate for new cleavages, indicating concerted endoproteolytic activity of
caspase-5
and -10.
...
PMID:Concerted antigen processing of a short viral antigen by human caspase-5 and -10. 2145 16